Hepatitis A Information Hepatitis A Information
logo
 
Hepatitis A
  •  
  • Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus. It can range from a mild illness lasting a few weeks to a severe illness lasting several months. Although rare, hepatitis A can cause death in some people. Hepatitis A usually spreads when a person unknowingly ingests the virus from objects, food, or drinks contaminated by small, undetected amounts of stool from an infected person.
  • Backgound: Recent outbreaks of hepatitis A virus (HAV) across the country have raised awareness of this serious and highly contagious illness. In close proximity to Chicago, Southeastern Michigan has been experiencing a HAV outbreak since August 2016 which has accelerated since August 2017 with a total of 431 cases, 348 hospitalizations (85.7% of cases) and 17 deaths (data as of October 18, 2017). The largest HAV outbreak since the introduction of vaccine has been ongoing in San Diego County since March 2017, with a total of 507 cases, 351 hospitalizations (69% of cases) and 19 deaths (data as of October 17, 2017).

    Symptoms: Symptoms of HAV include a viral prodrome of fatigue, malaise, fever, muscle aches, followed by nausea, vomiting, diarrhea (more common in children), abdominal pain and hepatitis (elevated serum aminotransferase levels) which can be associated with darkening of urine, pale-colored stools, and yellowing of the skin (jaundice) and/or eyes (scleral icterus). The most common symptom in adults is jaundice (>70%). Transmission occurs by fecal-oral route. Liver failure and death are more likely to occur in persons over the age of 50 years and those with chronic liver disease.

    Prevention: In order to protect Chicago’s highest risk individuals, Chicago Department of Public Health is asking all adult healthcare providers to vaccinate the following high risk groups with any hepatitis A vaccine currently in stock.
    • Homelessness or transient housing
    • Men who have sex with men
    • Users of injection and non-injection drugs
    • History of incarceration
    • Persons with chronic liver disease
    • Travelers*
    • Persons with clotting-factor disorders
    • Persons who work with non-human primates
    • Persons who anticipate close personal contact with an international adoptee

       PROVIDERS:

  • - Have a low threshold to report clinical suspicion for hepatitis A in high risk individuals to Chicago Department of Public Health (CDPH). High risk individuals include those who are homeless or living in transient housing, men who have sex with men, users of injection and non-injection drugs, and/or individuals with a history of incarceration.
  • - Use this Hepatitis A ER reporting form if you are in the ER and have clinical suspicion for hepatitis A in a high risk individual.
  • - In the setting of national outbreaks, vaccinate high risk patients for hepatitis A now.
  • - Consider repeating non-reactive (NR) hepatitis A IgM results in one week for clinically consistent cases.
  • LABORATORIES:

  • Save all reactive hepatitis A IgM specimens for 30 days.
Important Information Regarding PRIDE 2018 Important Information Regarding PRIDE 2018

Upcoming Pride events, students returning home from college, and nearby outbreaks may increase risk of  vaccine-preventable disease transmission.

This is the time of year to get all high-risk adults--including men who have sex with men (MSM) and HIV-positive individuals--up to date on recommended vaccines including:


o Meningococcal conjugate vaccine: Revaccination every 5 years
o Hepatitis A vaccine: One-time vaccination series (2 doses of Vaqta® or Havrix® or 3 doses of Twinrix®)
o Measles, Mumps, Rubella (MMR) vaccine: 2 documented doses, serologic proof of immunity, or at least 1 dose now if vaccination status is unknown. Consider 3rd dose of MMR to HIV-positive patients with CD4>200.

Please click HERE for more information

 

Information for Vaccinators Information for Vaccinators

If your organization is interested in receiving Hepatitis A vaccine to administer to high risk populations, please email  vaccine@cityofchicago.org or call 312-746-5382 to discuss.

Emergency Department Hepatitis A Vaccination Program FAQ

Standing orders for administering Hepatitis A Vaccine to Adults

Hepatitis A vaccination - information for health care providers 

Hepatitis A Vaccine Information Statement (VIS

Hepatitis A Patient Evaluation and Management for ED and Outpatient Providers

Manufacturer’s Vaccine Assistance Programs: The following is provided for adult clients who need help paying for vaccines, is for informational purposes only and is not an endorsement of any certain vaccine brand/manufacturer.

  • Merck Vaccine Patient Assistance Program for uninsured adults 19 years and older. Call 1-800-293-3881 from 8:00 a.m. to 8:00 p.m. EST, Mon. through Fri. or visit:  the website.
  •  
  • GlaxoSmithKline (GSK) Vaccines Access Program which provides adult GSK vaccines to eligible low income patients who do not have third party coverage for vaccines. Call 1-877-VAC-2911 (1-877-822-2911) or visit: https://www.gskforyou.com/vaccines-patient-assistance/.
Hepatitis A - Contact Us Hepatitis A - Contact Us

Clinical Contact

For Clinical questions please contact:

Dr. Marielle Fricchione, Immunization Medical Director

 312-746-5382

For clinical questions  during non-business hours, call 311 and ask for the communicable disease physician on-call.

 

Report all cases of hepatitis A to the Chicago Department of Public Health

Contact Communicable Disease Hepatitis Surveillance at (phone) 312-746-6197, (fax) 312-746-6388.

 

 If you have any hepatitis A vaccine expiring soon that you do not plan to use,

please contact ChicagoVFC@cityofchicago.org.

If your organization is interested in receiving Hepatitis A vaccine to administer to high risk populations, please email vaccine@cityofchicago.org or call 312-746-5382 to discuss.

If your organization has the ability and would like to distribute hygiene kits to homeless individuals, please call Donovan Robinson at 312-746-6286.